Abhishek Srivastava
Net worth: 93 $ as of 2024-04-29
Career history of Abhishek Srivastava
Former positions of Abhishek Srivastava
| Companies | Position | Start | End |
|---|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-08-03 | 2023-09-30 |
| ATHENEXPAR | Corporate Officer/Principal | - | - |
Training of Abhishek Srivastava
| University of Louisville School of Medicine | Doctorate Degree |
Statistics
International
| United States | 4 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Athenex, Inc.
 Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
- Stock Market
- Insiders
- Abhishek Srivastava
- Experience